MTOR and diabetic kidney disease: In diabetic nephropathy, lncRNA SPAG5-AS1 activates the AKT/mTOR pathway through upregulation of SPAG5 to foster apoptosis and abate autophagy in high glucose- (HG-) treated human podocytes (HPCs) [27].